UBC Medical Indonesia Tbk. vs Mandom Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Mandom Indonesia Tbk. trades at Rp2,750 (market cap 1.09T, 4K 24h volume). The key difference: Mandom Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 4K). Which is the better fit depends on your goals.
| LABS | TCID | |
|---|---|---|
Market Cap | 576.7B | 1.09T |
Volume | 3.48M | 4K |
Lot | 34.82K | 40 |
Turnover | 522.79M | 10.94M |
Average Price | 150.13 | 2,734 |
Value | 522.79M | 10.94M |
Indicative Equilibrium Price | 148 | — |
Indicative Equilibrium Volume | 350 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT. Mandom Indonesia Tbk (the Company), formely PT Tancho Indonesia Tbk was incorporated under the framework of the Foreign Capital Investment law dated November 5, 1969.The Company’s Articles of Association have been amended several times, including change of par value from Rp. 1000 to Rp. 500,- and change in name to PT Tancho Indonesia Tbk. Then increase in the authorized share capital to Rp 312 billion and issued and paid up capital to Rp. 78 billion. At an Extraordinary General Meeting of Share Holders dated November 2000, it was resolved to change the company’s name to PT Mandom Indonesia Tbk.The company is located in Jakarta and factories are located in Jakarta and Industrial Estate MM2100, Cibitung, West Java. The Company commenced commercial production in April 16, 1971.
Read more on TCID →